December 2018 - When do the patents on KEYTRUDA expire, and when will biosimilar KEYTRUDA enter the market?

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Merck Sharp Dohme	KEYTRUDA	pembrolizumab	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER	125514	001	2014-09-04	➤ Sign Up		➤ Sign Up	RX	Orphan	search
Merck Sharp Dohme	KEYTRUDA	pembrolizumab	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER	125514	001	2014-09-04	➤ Sign Up	3-V Biosciences, Inc. (Menlo Park, CA)	➤ Sign Up	RX	Orphan	search
Merck Sharp Dohme	KEYTRUDA	pembrolizumab	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER	125514	001	2014-09-04	➤ Sign Up	Plexxikon Inc. (Berkeley, CA)	➤ Sign Up	RX	Orphan	search
Merck Sharp Dohme	KEYTRUDA	pembrolizumab	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER	125514	001	2014-09-04	➤ Sign Up	NeuForm Pharmaceuticals, Inc. (Auburndale, MA)	➤ Sign Up	RX	Orphan	search
Merck Sharp Dohme	KEYTRUDA	pembrolizumab	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER	125514	001	2014-09-04	➤ Sign Up	Plexxikon Inc. (Berkeley, CA)	➤ Sign Up	RX	Orphan	search
Merck Sharp Dohme	KEYTRUDA	pembrolizumab	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER	125514	001	2014-09-04	➤ Sign Up	Advaxis, Inc. (Princeton, NJ) Merck Sharp & Dohme Corp. (Rahway, NJ)	➤ Sign Up	RX	Orphan	search
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source

Country

Document Number

Estimated Expiration